e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Clinical features of pulmonary thromboembolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic role of serum gamma-glutamyl transferase levels in patients with pulmonary thromboembolism
S. Ozsu, Y. Abul, S. Turkmen, Y. Bulbul, F. Oztuna, T. Ozlu (Trabzon, Turkey)
Source:
Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Session:
Clinical features of pulmonary thromboembolism
Session type:
Thematic Poster Session
Number:
2354
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ozsu, Y. Abul, S. Turkmen, Y. Bulbul, F. Oztuna, T. Ozlu (Trabzon, Turkey). Prognostic role of serum gamma-glutamyl transferase levels in patients with pulmonary thromboembolism. Eur Respir J 2011; 38: Suppl. 55, 2354
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020
The role of serum ischemia modified albumin level for the diagnosis of pulmonary thromboembolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
Prognostic role of serum bilirubin levels in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
The predictive prognostic role of elevated blood d-dimer and blood lactate in severe sepsis patients
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009
Elevated serum S100A4 levels in patients with silicosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Prognostic value of D-dimer, BNP and CRP in acute pulmonary thromboembolism and relationship with echocardiography
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008
Serum gamma-glutamyl transferase activity: A new prognostic factor in obstructive sleep apnea syndrome?
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
KL-6 compared to LDH as a prognostic factor in Caucasian patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004
Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005
The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004
Role of serum AGE/RAGEs in the differential diagnosis of pulmonary fibrosis
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis
Source: Annual Congress 2004 - Fibrosing lung diseases
Year: 2004
Serum adenosine deaminase (ADA) activities and neopterine levels during therapy in patients with pulmonary tuberculosis and community-acquired pneumonia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept